MongoDB, Inc. · MDB · FY2026 Q4 · Calendar Q1 2026
MongoDB: Strong FY26 close, with AI revenue still early
MongoDB's latest analysis supports a constructive operating trajectory: Atlas momentum, enterprise demand, and expanding AI usage provide growth support. The main qualification is that AI monetization remains early, while FY27 guidance was maintained rather than raised.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about MDB FY2026 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest quarter showed stronger reported growth and margin performance than the prior-quarter analysis, with Atlas momentum continuing and new large enterprise transactions highlighted. Management shifted the near-term emphasis toward execution on AI capabilities, EA feature parity, and go-to-market expansion while maintaining FY27 guidance.
Guidance delta
Maintained FY27 revenue guidance at $2.86–$2.90 billion, with margin expansion targets.
Key takeaways
- Atlas growth and large Enterprise Advanced deals supported a strong FY26 finish.
- Management said AI-related usage doubled year over year, while its revenue contribution remains early.
- The FY27 outlook was maintained as MongoDB invests in AI, EA feature parity, and go-to-market expansion.
Management priorities
- Deepen Voyage embeddings and other AI capabilities.
- Bring Enterprise Advanced to full feature parity with Atlas.
- Expand Japan, the U.S. federal business, self-serve, and AI-native customer coverage.
Follow MDB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 2, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| DA Davidson | Buy | Buy | Maintain | Oct 1, 2026 |
| UBS | Neutral | Neutral | Maintain | Sep 30, 2026 |
| Stifel | Buy | Buy | Maintain | Sep 30, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Sep 30, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 30, 2026 |
| Needham | Buy | Buy | Maintain | Sep 30, 2026 |
| Macquarie | Neutral | Neutral | Maintain | Sep 30, 2026 |
| Guggenheim | Buy | Buy | Maintain | Sep 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 30, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Sep 30, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 30, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 2, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Sep 2, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 2, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Sep 2, 2026 |
| Citigroup | Buy | Buy | Maintain | Sep 2, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 2, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 2, 2026 |
| Barclays | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 25, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 25, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 20, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 12, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 8, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Jun 2, 2026 |
| Wedbush | Outperform | Outperform | Maintain | May 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Dec 4, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Sep 19, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 27, 2025 |
| Monness, Crespi, Hardt | Buy | Neutral | Upgrade | Jun 5, 2025 |
| Loop Capital | Hold | Buy | Downgrade | May 20, 2025 |
| Keybanc | Overweight | Overweight | Maintain | Dec 10, 2024 |
| Redburn Atlantic | Sell | Neutral | Downgrade | Mar 19, 2024 |
| Capital One | Overweight | Equal Weight | Upgrade | Nov 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 10, 2023 |
| Redburn Partners | Neutral | Sell | Upgrade | Oct 18, 2022 |
| Nomura | Reduce | Reduce | Maintain | Dec 10, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Oct 29, 2019 |
| Citi | Buy | Buy | Maintain | Sep 5, 2019 |
| Compass Point | Neutral | Neutral | Maintain | Aug 13, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jun 19, 2019 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Apr 11, 2018 |
Named analyst price targets
Upside is calculated against the persisted previous close $351.73. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Rudy Kessinger | $415 | $353.36 | +18.0% | Sep 30, 2026 |
| Stifel Nicolaus | Brad Reback | $385 | $358.36 | +9.5% | Sep 30, 2026 |
| Piper Sandler | Hannah Rudoff | $470 | $356.22 | +33.6% | Sep 30, 2026 |
| BMO Capital | Analyst unavailable | $420 | $337.19 | +19.4% | Sep 30, 2026 |
| Mizuho Securities | Siti Panigrahi | $460 | $334.68 | +30.8% | Sep 29, 2026 |
| Monness | Brian White | $500 | $390.27 | +42.2% | Sep 2, 2026 |
| Stifel Nicolaus | Brad Reback | $465 | $389.85 | +32.2% | Sep 2, 2026 |
| UBS | Karl Keirstead | $410 | $380.95 | +16.6% | Sep 2, 2026 |
| Bernstein | Firoz Valliji | $484 | $380.5 | +37.6% | Sep 2, 2026 |
| RBC Capital | Rishi Jaluria | $465 | $390.89 | +32.2% | Sep 2, 2026 |
| Rosenblatt Securities | Blair Abernathy | $445 | $434.21 | +26.5% | Sep 2, 2026 |
| Canaccord Genuity | David Hynes | $480 | $434.21 | +36.5% | Sep 2, 2026 |
| Morgan Stanley | Sanjit Singh | $430 | $434.21 | +22.3% | Sep 2, 2026 |
| Morgan Stanley | Analyst unavailable | $519 | $434.21 | +47.6% | Sep 2, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $540 | $446.57 | +53.5% | Aug 31, 2026 |
| Monness | Brian White | $460 | $444.84 | +30.8% | Aug 31, 2026 |
| UBS | Karl Keirstead | $460 | $405.28 | +30.8% | Aug 24, 2026 |
| Evercore ISI | Analyst unavailable | $525 | $420.37 | +49.3% | Aug 21, 2026 |
| Goldman Sachs | Matthew Martino | $453 | $434.62 | +28.8% | Aug 19, 2026 |
| Stifel Nicolaus | Brad Reback | $475 | $443.23 | +35.0% | Aug 18, 2026 |
| Guggenheim | Howard Ma | $560 | $438.7 | +59.2% | Aug 18, 2026 |
| KGI Securities | Analyst unavailable | $470 | $354.22 | +33.6% | Jul 8, 2026 |
| Tigress Financial | Ivan Feinseth | $515 | $398.54 | +46.4% | Jun 2, 2026 |
| Stifel Nicolaus | Brad Reback | $435 | $319.82 | +23.7% | May 29, 2026 |
| Needham | Mike Cikos | $400 | $325.68 | +13.7% | May 29, 2026 |
| UBS | Analyst unavailable | $366 | $325.68 | +4.1% | May 29, 2026 |
| Macquarie | Steve Koenig | $315 | $325.68 | -10.4% | May 29, 2026 |
| Morgan Stanley | Sanjit Singh | $380 | $325.68 | +8.0% | May 29, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $416 | $326.13 | +18.3% | May 26, 2026 |
| Wedbush | Daniel Ives | $380 | $258.97 | +8.0% | Mar 3, 2026 |
| Needham | Mike Cikos | $300 | $325.01 | -14.7% | Mar 3, 2026 |
| BMO Capital | Keith Bachman | $340 | $325.01 | -3.3% | Mar 3, 2026 |
| D.A. Davidson | Rudy Kessinger | $385 | $312.66 | +9.5% | Feb 25, 2026 |
| RBC Capital | Analyst unavailable | $500 | $389.2 | +42.2% | Jan 15, 2026 |
| Goldman Sachs | Matthew Martino | $475 | $399.65 | +35.0% | Jan 5, 2026 |
| D.A. Davidson | Rudy Kessinger | $465 | $405.54 | +32.2% | Dec 2, 2025 |
| Piper Sandler | Hannah Rudoff | $490 | $406.64 | +39.3% | Dec 2, 2025 |
| Oppenheimer | Ittai Kidron | $450 | $405.94 | +27.9% | Dec 2, 2025 |
| Bernstein | Firoz Valliji | $452 | $407.34 | +28.5% | Dec 2, 2025 |
| Stifel Nicolaus | Brad Reback | $375 | $352.99 | +6.6% | Nov 4, 2025 |
| BMO Capital | Keith Bachman | $415 | $353.02 | +18.0% | Nov 4, 2025 |
| RBC Capital | Rishi Jaluria | $405 | $352.48 | +15.1% | Nov 4, 2025 |
| Truist Financial | Miller Jump | $400 | $369.05 | +13.7% | Nov 3, 2025 |
| Wells Fargo | Ryan MacWilliams | $430 | $310.38 | +22.3% | Sep 30, 2025 |
| Scotiabank | Patrick Colville | $160 | $173.5 | -54.5% | Apr 25, 2025 |
| Wells Fargo | Analyst unavailable | $225 | $192.98 | -36.0% | Mar 6, 2025 |
| Cantor Fitzgerald | Thomas Blakey | $344 | $251.99 | -2.2% | Mar 5, 2025 |
| UBS | Blair Abernethy | $350 | $254.38 | -0.5% | Mar 4, 2025 |
| Loop Capital Markets | Yun Kim | $400 | $322.4 | +13.7% | Dec 2, 2024 |
| Goldman Sachs | Kash Rangan | $340 | $290.79 | -3.3% | Aug 30, 2024 |
| Morgan Stanley | Sanjit Singh | $340 | $282.42 | -3.3% | Aug 30, 2024 |
| Truist Financial | Miller Jump | $320 | $245.72 | -9.0% | Aug 30, 2024 |
| KeyBanc | Eric Heath | $278 | $220.09 | -21.0% | Jun 13, 2024 |
| Scotiabank | Patrick Colville | $250 | $236.06 | -28.9% | Jun 3, 2024 |
| Stifel Nicolaus | Brad Reback | $300 | $310 | -14.7% | May 31, 2024 |
| Oppenheimer | Ittai Kidron | $300 | $310 | -14.7% | May 31, 2024 |
| Loop Capital Markets | Yun Kim | $315 | $310 | -10.4% | May 31, 2024 |
| Piper Sandler | Brent Bracelin | $290 | $310 | -17.6% | May 31, 2024 |
| Piper Sandler | Brent Bracelin | $350 | $310 | -0.5% | May 31, 2024 |
| Robert W. Baird | William Power | $305 | $310 | -13.3% | May 31, 2024 |
| Canaccord Genuity | David Hynes | $325 | $310 | -7.6% | May 31, 2024 |
| Morgan Stanley | Sanjit Singh | $320 | $310 | -9.0% | May 31, 2024 |
| Mizuho Securities | Matthew Broome | $250 | $310 | -28.9% | May 31, 2024 |
| Truist Financial | Miller Jump | $300 | $310 | -14.7% | May 31, 2024 |
| Barclays | Raimo Lenschow | $290 | $310 | -17.6% | May 31, 2024 |
| Wells Fargo | Andrrew Nowinski | $450 | $335.86 | +27.9% | May 29, 2024 |
| Loop Capital Markets | Yun Kim | $415 | $340.16 | +18.0% | Apr 22, 2024 |
| D.A. Davidson | Rudy Kessinger | $430 | $384.84 | +22.3% | Mar 8, 2024 |
| Truist Financial | Miller Jump | $500 | $407.16 | +42.2% | Mar 7, 2024 |
| Piper Sandler | Brent Bracelin | $500 | $387.42 | +42.2% | Dec 6, 2023 |
| Truist Financial | Miller Jump | $420 | $393.14 | +19.4% | Jun 23, 2023 |
| Needham | Mike Cikos | $430 | $373.14 | +22.3% | Jun 2, 2023 |
| RBC Capital | Rishi Jaluria | $235 | $209.76 | -33.2% | Mar 9, 2023 |
| Needham | Mike Cikos | $205.93 | $211.09 | -41.5% | Mar 9, 2023 |
| Bernstein | Firoz Valliji | $282 | $210.66 | -19.8% | Feb 17, 2023 |
| Needham | Needham Needham | $240 | $196.84 | -31.8% | Jan 2, 2023 |
| Piper Sandler | Brent Bracelin | $270 | $175.96 | -23.2% | Dec 7, 2022 |
| JMP Securities | Patrick Walravens | $215 | $144.69 | -38.9% | Dec 7, 2022 |
| Barclays | Raimo Lenschow | $360 | $244.12 | +2.4% | Sep 1, 2022 |
| Mizuho Securities | Matthew Broome | $300 | $322.86 | -14.7% | Sep 1, 2022 |
| Needham | Mike Cikos | $330 | $322.86 | -6.2% | Sep 1, 2022 |
| RBC Capital | Rishi Jaluria | $350 | $322.86 | -0.5% | Sep 1, 2022 |
| RBC Capital | Rishi Jaluria | $350 | $322.86 | -0.5% | Sep 1, 2022 |
| RBC Capital | Rishi Jaluria | $375 | $249.75 | +6.6% | Jun 17, 2022 |
| Piper Sandler | Brent Bracelin | $430 | $241.81 | +22.3% | Jun 2, 2022 |
| Goldman Sachs | Kash Rangan | $435 | $286.7 | +23.7% | Jun 2, 2022 |
| Morgan Stanley | Sanjit Singh | $368 | $286.7 | +4.6% | Jun 2, 2022 |
| Mizuho Securities | Matthew Broome | $270 | $241.81 | -23.2% | Jun 2, 2022 |
| Mizuho Securities | Matthew Broome | $270 | $286.7 | -23.2% | Jun 2, 2022 |
| Needham | Mike Cikos | $310 | $286.7 | -11.9% | Jun 2, 2022 |
| RBC Capital | Rishi Jaluria | $325 | $286.7 | -7.6% | Jun 2, 2022 |
| Citigroup | Tyler Radke | $405 | $237.15 | +15.1% | May 31, 2022 |
| Morgan Stanley | Sanjit Singh | $378 | $248.1 | +7.5% | May 23, 2022 |
| Barclays | Raimo Lenschow | $330 | $248.1 | -6.2% | May 21, 2022 |
| Mizuho Securities | Matthew Broome | $270 | $245.33 | -23.2% | May 20, 2022 |
| UBS | Karl Keirstead | $450 | $390.5 | +27.9% | Mar 21, 2022 |
| Citigroup | Tyler Radke | $525 | $334.09 | +49.3% | Mar 9, 2022 |
| Needham | Mike Cikos | $362 | $334.09 | +2.9% | Mar 9, 2022 |
| Mizuho Securities | Matthew Broome | $325 | $334.09 | -7.6% | Mar 9, 2022 |
| RBC Capital | Rishi Jaluria | $505 | $281.74 | +43.6% | Mar 8, 2022 |
| Mizuho Securities | Matthew Broome | $400 | $390.18 | +13.7% | Feb 21, 2022 |
| Tigress Financial | Ivan Feinseth | $630 | $427.17 | +79.1% | Feb 11, 2022 |
| Barclays | Raimo Lenschow | $556 | $396.89 | +58.1% | Jan 17, 2022 |
| Macquarie | Frederick Havemeyer | $552 | $499.82 | +56.9% | Dec 7, 2021 |
| Piper Sandler | Brent Bracelin | $585 | $499.82 | +66.3% | Dec 7, 2021 |
| Argus Research | Joseph Bonner | $550 | $489.75 | +56.4% | Sep 7, 2021 |
| SMBC Nikko | Steven Koenig | $393 | $365.57 | +11.7% | Jul 6, 2021 |
Track every rating change on MDB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMongoDB, Inc. serves as a global provider of a versatile database platform. The company's offerings feature MongoDB Enterprise Advanced, a sophisticated commercial database server designed for corporate clients, which can be deployed in cloud, on-premises, or hybrid environments. It also presents MongoDB Atlas, a fully managed, multi-cloud database-as-a-service (DBaaS) solution. For developers seeking to start with MongoDB, the company offers a free, downloadable Community Server that includes fundamental database functionalities. Beyond its core database products, MongoDB, Inc. provides professional services such as consulting and training. Founded in 2007 and based in New York, New York, the company was formerly known as 10gen, Inc. before adopting the name MongoDB, Inc. in August 2013.
Historical context
All MDB earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ACN Accenture plc | FY2026 Q4 · Calendar Q4 2026 | +3.5% | +15.8% | Accenture: AI demand supports strong Q4, while pricing and geopolitics remain risks |
| JBL Jabil Inc. | FY2026 Q4 · Calendar Q3 2026 | +8.1% | -10.0% | Jabil enters FY2027 with AI-led growth and capacity risks |
| MU Micron Technology, Inc. | FY2026 Q4 · Calendar Q3 2026 | +5.4% | +0.0% | Micron: Strong AI Memory Demand, Higher Capex, and HBM4E Ahead |
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the MDB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-10-02T10:06:03.871854+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-02T10:06:03.869081+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-02. For educational purposes only; not investment advice.